WASHINGTON, June 8, 2011 /PRNewswire/ -- Fourteen leading scientists and advocacy experts in vaccines and infectious diseases have announced the formation of a new international Foundation to advance and accelerate vaccine research and development against infectious diseases.

AUSTIN, Texas, May 12, 2011 /PRNewswire/ -- Rules-Based Medicine, Inc. a leading provider of multiplexed protein biomarker services will be a collaborator on the Institut Pasteur research project Milieu Interieur (the environment within), funded through a LabEx grant from the French government.

BIOVISION, LYON, France, March 29, 2011 /PRNewswire/ -- Institut Pasteur of Shanghai announces today the creation of its global biotech accelerator company Advance BioChina. Advance BioChina is an R&D-focused for-profit organization that positions itself as the gateway to China for global biotech companies.

Scientists have discovered a new type of mosquito that is unlike any that have been documented before and could complicate the fight against malaria even further.

AMSTERDAM, January 10, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced today that it has entered into an agreement with Institut Pasteur, Paris, France, and a group of French research institutes (together the "Consortium") to support clinical development of a novel gene therapy to treat Sanfilippo B. This rare genetic disease affecting new-born children leads to progressive neuronal degeneration and death.